Mer-NF5003B, E and F, novel sesquiterpenoids as avian myeloblastosis virus protease inhibitors produced by Stachybotrys sp.
Central Research Laboratories, Mercian Corporation, Kanagawa, Japan.
R
R
Kaneto
K
K
Dobashi
I
I
Kojima
K
K
Sakai
N
N
Shibamoto
T
T
Yoshioka
H
H
Nishida
R
R
Okamoto
H
H
Akagawa
S
S
Mizuno
D000595:Amino Acid Sequence; D000998:Antiviral Agents / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology*; D009189:Avian Myeloblastosis Virus / Q000187:drug effects / Q000201:enzymology*; D001572:Benzofurans / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology*; D005285:Fermentation; D009682:Magnetic Resonance Spectroscopy; D008968:Molecular Conformation; D008969:Molecular Sequence Data; D015394:Molecular Structure; D011480:Protease Inhibitors / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology*; D016339:Spectrometry, Mass, Fast Atom Bombardment; D013141:Spiro Compounds / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology*; D013191:Stachybotrys / Q000378:metabolism*
D000998:Antiviral Agents; D001572:Benzofurans; D011480:Protease Inhibitors; D013141:Spiro Compounds; C088519:Mer NF5003F; C088504:Mer NF5003B; C088505:Mer NF5003E